← Eichor
Condition: Monocytic Leukemia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Monocytic Leukemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Cladribine Venetoclax in Monocytic AML
Phase 2 · 1 location(s) · University of Colorado, Denver · NCT06232655Venetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic Leukemia
Phase 2 · 3 location(s) · Chinese PLA General Hospital · NCT07512700Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers
Phase 2 · 10 location(s) · Fred Hutchinson Cancer Center · NCT03779854Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myel
Phase 2 · 3 location(s) · Fred Hutchinson Cancer Center · NCT03970096Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia
Phase 2 · 1 location(s) · University of Washington · NCT03737955211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Le
Phase 1/Phase 2 · 1 location(s) · Fred Hutchinson Cancer Center · NCT03670966Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
EARLY_Phase 1 · 1 location(s) · Omar Aljitawi · NCT03964506Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment
Phase 2 · 2 location(s) · OHSU Knight Cancer Institute · NCT06504459A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
Phase 1 · 7 location(s) · Solu Therapeutics, Inc · NCT06950034Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Ne
Phase 2 · 1 location(s) · University of Washington · NCT04282187Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia
Phase 1 · 1 location(s) · University of Colorado, Denver · NCT06429449Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia
Phase 2 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT05566054Halt Aging in Survivors of Blood Cancers
NA · 1 location(s) · University of Nebraska · NCT07292272
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.